Outcomes and prognostic insights in primary tracheal cancer: a multicenter retrospective study.

ABSTRACT:

Background

Primary tracheal tumors are exceedingly rare, comprising less than 0.1% of all respiratory system cancers and only 0.02-0.04% of all malignancies. Their rarity and clinical heterogeneity present significant challenges for diagnosis and treatment. This study aimed to evaluate treatment outcomes, identify prognostic factors, and compare recent findings with historical data to assess changes in clinical practice.

Methods

We conducted a retrospective analysis of 31 patients treated between 2017 and 2022 at Maria Skłodowska-Curie National Research Institute of Oncology, Warsaw and Gliwice, Poland. Demographic, clinical, pathological, and treatment-related data were collected. Overall survival (OS) was estimated using the Kaplan-Meier method, and prognostic factors were

SUBMITTER: Piorek A 

PROVIDER: S-EPMC12541878 | biostudies-literature | 2025 Sep

REPOSITORIES: biostudies-literature